Signaling through cholesterol esterification: A new pathway for the cholecystokinin 2 receptor involved in cell growth and invasion

Journal of Lipid Research

Volumn 50, Issue 11, 2009, Pages 2203-2211

  Paillasse, Michael R ^a,b   de Medina, Philippe ^a,b   Amouroux, Guillaume ^a   Mhamdi, Loubna ^a,b   Poirot, Marc ^a,c   Silvente Poirot, Sandrine ^a,c  

^a INSERM   (France)

^b Affichem   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Acyl CoA:cholesterol acyltransferase; Autocrine stimulation; Cancer; Cholesteryl ester; Constitutively active mutant; G protein coupled receptor; Gastrin receptor; Glioma

Indexed keywords

3 DECYLDIMETHYLSILYL N [2 (4 METHYLPHENYL) 1 PHENYLETHYL]PROPIONAMIDE; CHOLECYSTOKININ B RECEPTOR; CHOLESTEROL ACYLTRANSFERASE; CHOLESTEROL ESTER; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C ZETA;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CANCER INVASION; CELL CULTURE; CELL PROLIFERATION; CHOLESTEROL ESTERIFICATION; CULTURE MEDIUM; ENZYME ACTIVITY; GLIOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; BENZODIAZEPINES; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CHOLESTEROL; CHOLESTEROL ESTERS; ESTERIFICATION; HORMONE ANTAGONISTS; HUMANS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MUTATION; NEOPLASM INVASIVENESS; NIH 3T3 CELLS; PROTEIN KINASE C; RECEPTOR, CHOLECYSTOKININ B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEROL O-ACYLTRANSFERASE; TRANSFECTION;

EID: 70350370454     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M800668-JLR200     Document Type: Article

References (51)

1. Rehfeld, J. F. 2004. Cholecystokinin. Best Pract. Res. Clin. Endocrinol. Metab. 18: 569-586.
2. Dockray, G., R. Dimaline, and A. Varro. 2005. Gastrin: old hormone, new functions. Pflugers Arch. 449: 344-355.
3. Iwase, K., B. M. Evers, M. R. Hellmich, Y. S. Guo, S. Higashide, H. J. Kim, and C. M. Townsend, Jr. 1997. Regulation of growth of human gastric cancer by gastrin and glycine-extended progastrin. Gastroenterology. 113: 782-790.
4. Caplin, M., K. Khan, S. Grimes, D. Michaeli, K. Savage, R. Pounder, and A. Dhillon. 2001. Effect of gastrin and anti-gastrin antibodies on proliferation of hepatocyte cell lines. Dig. Dis. Sci. 46: 1356-1366.
5. Moody, T. W., and R. T. Jensen. 2001. CI-988 inhibits growth of small cell lung cancer cells. J. Pharmacol. Exp. Ther. 299: 1154-1160.
6. Rozengurt, E., and J. H. Walsh. 2001. Gastrin, CCK, signaling, and cancer. Annu. Rev. Physiol. 63: 49-76.
7. Stubbs, M., K. Khan, R. G. Wickremasinghe, K. Ganeshaguru, and M. E. Caplin. 2005. CCK2 gastrin receptor as a potential target for therapy in leukaemia cell lines. Oncol. Rep. 14: 1055-1058.
8. Savage, K., H. A. Waller, M. Stubbs, K. Khan, S. A. Watson, P. A. Clarke, S. Grimes, D. Michaeli, A. P. Dhillon, and M. E. Caplin. 2006. Targeting of cholecystokinin B/gastrin receptor in colonic, pancreatic and hepatocellular carcinoma cell lines. Int. J. Oncol. 29: 1429-1435.
9. Staley, J., R. T. Jensen, and T. W. Moody. 1990. CCK antagonists interact with CCK-B receptors on human small cell lung cancer cells. Peptides. 11: 1033-1036.
10. Nagata, A., M. Ito, N. Iwata, J. Kuno, H. Takano, O. Minowa, K. Chihara, T. Matsui, and T. Noda. 1996. G protein-coupled cholecystokinin-B/ gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo. Proc. Natl. Acad. Sci. USA. 93: 11825-11830.
11. Schmitz, F., M. N. Goke, J. M. Otte, H. Schrader, B. Reimann, M. L. Kruse, E. G. Siegel, J. Peters, K. H. Herzig, U. R. Folsch, et al. 2001. Cellular expression of CCK-A and CCK-B/gastrin receptors in human gastric mucosa. Regul. Pept. 102: 101-110.
12. Smith, J. P., A. H. Shih, M. G. Wotring, P. J. McLaughlin, and I. S. Zagon. 1998. Characterization of CCK-B/gastrin-like receptors in human gastric carcinoma. Int. J. Oncol. 12: 411-419.
13. Reubi, J. C., J. C. Schaer, and B. Waser. 1997. Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors. Cancer Res. 57: 1377-1386.
14. McWilliams, D. F., S. A. Watson, D. M. Crosbee, D. Michaeli, and R. Seth. 1998. Coexpression of gastrin and gastrin receptors (CCK-B and delta CCK-B) in gastrointestinal tumour cell lines. Gut. 42: 795-798.
15. Caplin, M., K. Khan, K. Savage, J. Rode, A. Varro, D. Michaeli, S. Grimes, B. Brett, R. Pounder, and A. Dhillon. 1999. Expression and processing of gastrin in hepatocellular carcinoma, fibrolamellar carcinoma and cholangiocarcinoma. J. Hepatol. 30: 519-526.
16. Blackmore, M., and B. H. Hirst. 1992. Autocrine stimulation of growth of AR4-2J rat pancreatic tumour cells by gastrin. Br. J. Cancer. 66: 32-38.
17. Caplin, M., K. Savage, K. Khan, B. Brett, J. Rode, A. Varro, and A. Dhillon. 2000. Expression and processing of gastrin in pancreatic adenocarcinoma. Br. J. Surg. 87: 1035-1040.
18. Smith, J. P., A. Shih, Y. Wu, P. J. McLaughlin, and I. S. Zagon. 1996. Gastrin regulates growth of human pancreatic cancer in a tonic and autocrine fashion. Am. J. Physiol. 270: R1078-R1084.
19. Grabowska, A. M., and S. A. Watson. 2007. Role of gastrin peptides in carcinogenesis. Cancer Lett. 257: 1-15.
20. Oikonomou, E., M. Buchfelder, and E. F. Adams. 2008. Cholecystokinin (CCK) and CCK receptor expression by human gliomas: evidence for an autocrine/paracrine stimulatory loop. Neuropeptides. 42: 255-265.
21. Gales, C., D. Sanchez, M. Poirot, S. Pyronnet, L. Buscail, D. Cussac, L. Pradayrol, D. Fourmy, and S. Silvente-Poirot. 2003. High tumorigenic potential of a constitutively active mutant of the cholecystokinin 2 receptor. Oncogene. 22: 6081-6089.
22. Chang, A. J., D. H. Song, and M. M. Wolfe. 2006. Attenuation of peroxisome proliferator-activated receptor gamma (PPARgamma) mediates gastrin-stimulated colorectal cancer cell proliferation. J. Biol. Chem. 281: 14700-14710.
23. Hansen, T. O., R. Borup, T. Marstrand, J. F. Rehfeld, and F. C. Nielsen. 2008. Cholecystokinin-2 receptor mediated gene expression in neuronal PC12 cells. J. Neurochem. 104: 1450-1465.
24. Simons, K., and E. Ikonen. 2000. How cells handle cholesterol. Science. 290: 1721-1726.
25. Pucadyil, T. J., and A. Chattopadhyay. 2006. Role of cholesterol in the function and organization of G-protein coupled receptors. Prog. Lipid Res. 45: 295-333.
26. Ikonen, E. 2008. Cellular cholesterol trafficking and compartmentalization. Nat. Rev. Mol. Cell Biol. 9: 125-138.
27. Schroepfer, G. J., Jr. 2000. Oxysterols: modulators of cholesterol metabolism and other processes. Physiol. Rev. 80: 361-554.
28. Gebhard, R. L., R. V. Clayman, W. F. Prigge, R. Figenshau, N. A. Staley, C. Reesey, and A. Bear. 1987. Abnormal cholesterol metabolism in renal clear cell carcinoma. J. Lipid Res. 28: 1177-1184.
29. Dessi, S., B. Batetta, C. Anchisi, P. Pani, P. Costelli, L. Tessitore, and F. M. Baccino. 1992. Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130). Br. J. Cancer. 66: 787-793.
30. Dessi, S., B. Batetta, A. Pani, O. Spano, F. Sanna, M. Putzolu, R. Bonatesta, S. Piras, and P. Pani. 1997. Role of cholesterol synthesis and esterification in the growth of CEM and MOLT4 lymphoblastic cells. Biochem. J. 321: 603-608.
31. Tosi, M. R., G. Bottura, P. Lucchi, A. Reggiani, A. Trinchero, and V. Tugnoli. 2003. Cholesteryl esters in human malignant neoplasms. Int. J. Mol. Med. 11: 95-98.
32. Matsumoto, K., Y. Fujiwara, R. Nagai, M. Yoshida, and S. Ueda. 2008. Expression of two isozymes of acyl-coenzyme A: cholesterol acyltransferase-1 and -2 in clear cell type renal cell carcinoma. Int. J. Urol. 15: 166-170.
33. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
34. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
35. de Medina, P., B. L. Payre, J. Bernad, I. Bosser, B. Pipy, S. Silvente-Poirot, G. Favre, J. C. Faye, and M. Poirot. 2004. Tamoxifen is a potent inhibitor of cholesterol esterification and prevents the formation of foam cells. J. Pharmacol. Exp. Ther. 308: 1165-1173.
36. Ross, A. C., K. J. Go, J. G. Heider, and G. H. Rothblat. 1984. Selective inhibition of acyl coenzyme A:cholesterol acyltransferase by compound 58-035. J. Biol. Chem. 259: 815-819.
37. Poulin, R., L. Lu, B. Ackermann, P. Bey, and A. E. Pegg. 1992. Mechanism of the irreversible inactivation of mouse ornithine decarboxylase by alpha-difluoromethylornithine. Characterization of sequences at the inhibitor and coenzyme binding sites. J. Biol. Chem. 267: 150-158.
38. Gschwendt, M., S. Dieterich, J. Rennecke, W. Kittstein, H. J. Mueller, and F. J. Johannes. 1996. Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett. 392: 77-80.
39. Brown, M. S., Y. K. Ho, and J. L. Goldstein. 1980. The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters. J. Biol. Chem. 255: 9344-9352.
40. Nishida, A., K. Miyata, R. Tsutsumi, H. Yuki, S. Akuzawa, A. Kobayashi, T. Kamato, H. Ito, M. Yamano, Y. Katuyama, et al. 1994. Pharmacological profile of (R)-1-[2,3-dihydro-1-(2'-methylphenacyl)-2-oxo-5-phenyl-1H-1, 4-benzodiazepin-3-yl]-3-(3-methylphenyl)urea (YM022), a new potent and selective gastrin/cholecystokinin-B receptor antagonist, in vitro and in vivo. J. Pharmacol. Exp. Ther. 269: 725-731.
41. Chang, R. S., T. B. Chen, M. G. Bock, R. M. Freidinger, R. Chen, A. Rosegay, and V. J. Lotti. 1989. Characterization of the binding of [3H]L-365,260: a new potent and selective brain cholecystokinin (CCK-B) and gastrin receptor antagonist radioligand. Mol. Pharmacol. 35: 803-808.
42. Batetta, B., A. Pani, M. Putzolu, F. Sanna, R. Bonatesta, S. Piras, O. Spano, M. F. Mulas, and S. Dessi. 1999. Correlation between cholesterol esterification, MDR1 gene expression and rate of cell proliferation in CEM and MOLT4 cell lines. Cell Prolif. 32: 49-61.
43. Nygren, C., H. von Holst, J. E. Mansson, and P. Fredman. 1997. Increased levels of cholesterol esters in glioma tissue and surrounding areas of human brain. Br. J. Neurosurg. 11: 216-220.
44. Beckonert, O., J. Monnerjahn, U. Bonk, and D. Leibfritz. 2003. Visualizing metabolic changes in breast-cancer tissue using 1H-NMR spectroscopy and self-organizing maps. NMR Biomed. 16: 1-11.
45. Tosi, M. R., and V. Tugnoli. 2005. Cholesteryl esters in malignancy. Clin. Chim. Acta. 359: 27-45.
46. Tugnoli, V., M. R. Tosi, A. Tinti, A. Trinchero, G. Bottura, and G. Fini. 2001. Characterization of lipids from human brain tissues by multinuclear magnetic resonance spectroscopy. Biopolymers. 62: 297-306.
47. Tugnoli, V., A. Reggiani, R. Beghelli, V. Tomaselli, A. Trinchero, and M. R. Tosi. 2003. Magnetic resonance spectroscopy and high performance liquid chromatography of neoplastic human renal tissues. Anticancer Res. 23: 1541-1548.
48. Napolitano, M., M. Avella, N. T. Goode, K. M. Botham, and E. Bravo. 2004. Cholesterol esterification in human monocyte-derived macrophages is inhibited by protein kinase C with dual roles for mitogen activated protein kinases. Cell Biol. Int. 28: 717-725.
49. Post, S. M., J. P. Zoeteweij, M. H. Bos, E. C. de Wit, R. Havinga, F. Kuipers, and H. M. Princen. 1999. Acyl-coenzyme A:cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7alpha-hydroxylase in cultured rat hepatocytes and in vivo in the rat. Hepatology. 30: 491-500.
50. Payre, B., P. de Medina, N. Boubekeur, L. Mhamdi, J. Bertrand-Michel, F. Terce, I. Fourquaux, D. Goudouneche, M. Record, M. Poirot, et al. 2008. Microsomal antiestrogen-binding site ligands induce growth control and differentiation of human breast cancer cells through the modulation of cholesterol metabolism. Mol. Cancer Ther. 7: 3707-3718.
51. de Medina, P., B. Payre, N. Boubekeur, J. Bertrand-Michel, F. Terce, S. Silvente-Poirot, and M. Poirot. 2009. Ligands of the antiestrogen binding site induce active cell death and autophagy in human breast cancer cells through the modulation of cholesterol metabolism. Cell Death Differ. 16: 1372-1384.